Nilay Yuksel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nilay Yuksel has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
Emine Akcay
Yildirim Beyazit University, Ankara Ataturk Education and Research Hospital, Department of Ophthalmology, Ankara, Turkey
7 shared publicationsMediha Dilek Ozer
Department of Ophthalmology, Kahramanmaras Necip Fazil City Hospital, Kahramanmaras - Turkey
4 shared publicationsUmut Ozen
Department of Ophthalmology, Ataturk Training and Research Hospital, Ankara - Turkey
4 shared publications- Atike Burcin Tefon Aribas
Department of Ophthalmology, Ankara Bilkent City Hospital, Ankara, Turkey
3 shared publications Erdem Yuksel
Department of Ophthalmology, Medical Faculty, Kastamonu University, Kastamonu, Turkey
3 shared publicationsFerhan Guler
Department of Ophthalmology, Yildirim Beyazit University, Ankara Bilkent City Hospital, Ankara, Turkiye; and
3 shared publications
Latest Publications
- 27 July 2026
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
Histopathological Characteristics of the Levator Muscle in Congenital and Acquired Ptosis With Varying Levator Function
Purpose: Levator function (LF) is a key parameter in the evaluation and surgical planning of blepharoptosis; however, it does not always correlate with clinical severity or outcomes. This study aimed to compare the histopathological characteristics of the levator palpebrae superioris (LPS) muscle in congenital and acquired (involutional) ptosis with different LF levels. Methods: This retrospective study included 38 eyelids from patients with congenital or acquired ptosis who underwent anterior levator surgery. Patients were categorized into 3 groups based on LF: congenital ptosis with LF >5 mm (group 1, n=10), acquired ptosis with LF 9 to 13 mm (group 2, n=12), and acquired ptosis with LF >14 mm (group 3, n=16). Excised levator aponeurosis and muscle tissues were examined histopathologically. Muscle tissue, fat infiltration, fibrosis, edema, and inflammation were evaluated. Results: Muscle tissue was present in all specimens. Fat infiltration differed significantly among groups ( P =0.029), being more frequent in groups 1 and 2 compared with group 3 ( P =0.041 and 0.039), with no difference between groups 1 and 2 ( P =0.218). Severe fibrosis was observed only in group 1, without statistical significance ( P =0.193). Edema and inflammation showed no significant differences between groups ( P =0.771, P =0.359). Correlation analysis revealed a significant negative correlation between LF and fat infiltration ( r =−0.23, P =0.017) and a positive correlation between LF and muscle content ( r =0.27, P =0.011) in groups 2 and 3. Conclusion: Fat infiltration and muscle content are associated with LF and may partially explain functional variability independent of ptosis etiology.
- 27 July 2026
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
Histopathological Characteristics of the Levator Muscle in Congenital and Acquired Ptosis With Varying Levator Function
Purpose: Levator function (LF) is a key parameter in the evaluation and surgical planning of blepharoptosis; however, it does not always correlate with clinical severity or outcomes. This study aimed to compare the histopathological characteristics of the levator palpebrae superioris (LPS) muscle in congenital and acquired (involutional) ptosis with different LF levels. Methods: This retrospective study included 38 eyelids from patients with congenital or acquired ptosis who underwent anterior levator surgery. Patients were categorized into 3 groups based on LF: congenital ptosis with LF >5 mm (group 1, n=10), acquired ptosis with LF 9 to 13 mm (group 2, n=12), and acquired ptosis with LF >14 mm (group 3, n=16). Excised levator aponeurosis and muscle tissues were examined histopathologically. Muscle tissue, fat infiltration, fibrosis, edema, and inflammation were evaluated. Results: Muscle tissue was present in all specimens. Fat infiltration differed significantly among groups ( P =0.029), being more frequent in groups 1 and 2 compared with group 3 ( P =0.041 and 0.039), with no difference between groups 1 and 2 ( P =0.218). Severe fibrosis was observed only in group 1, without statistical significance ( P =0.193). Edema and inflammation showed no significant differences between groups ( P =0.771, P =0.359). Correlation analysis revealed a significant negative correlation between LF and fat infiltration ( r =−0.23, P =0.017) and a positive correlation between LF and muscle content ( r =0.27, P =0.011) in groups 2 and 3. Conclusion: Fat infiltration and muscle content are associated with LF and may partially explain functional variability independent of ptosis etiology.
- 14 January 2026
- Published by Wolters Kluwer Health in Cornea
Impact of Systemic EGFR Inhibitors on Meibomian Glands: A Meibographic Analysis With Clinical Correlations
Purpose: Epidermal growth factor receptor (EGFR) signaling promotes meibomian gland (MG) epithelial and mesenchymal cell proliferation and is involved in MG morphogenesis. This study aimed to evaluate the impact of systemic EGFR inhibitor (EGFR-I) therapy on MG status using meibography, and its association with ocular surface clinical parameters. Methods: In this prospective study, 39 patients with no prior history of ocular surface disease who were scheduled to receive systemic EGFR-I therapy for various malignancies were enrolled. All participants underwent Schirmer test, tear film break-up time, ocular surface disease index questionnaire, noninvasive tear break-up time, and noncontact meibography using Sirius topography at baseline, and at 1 and 3 months after treatment initiation. MG loss was quantified and staged based on meibographic analysis. Results: Of the 39 participants, 28 (72%) were female and 11 (28%) were male, with a mean age of 61.8 ± 11 years. Baseline Schirmer test and tear film break-up time values (15.6 ± 4.2 mm and 13.2 ± 3.5 seconds) showed a significant reduction at 1 month (13.8 ± 3.8 mm; 11.1 ± 3.0 seconds), with a further decline observed at 3 months (8.1 ± 3.1 mm; 7.4 ± 2.7 seconds) ( P < 0.001). The mean ocular surface disease index score increased from 7.7 ± 6.9 at baseline to 11.6 ± 7.3 at 1 month and 30.3 ± 14.6 at 3 months ( P < 0.001). Noninvasive tear break-up time values decreased significantly at 3 months (5.9 ± 2.6 seconds) relative to baseline (11.1 ± 4.5 seconds) ( P < 0.001). Meibographic assessments revealed a progressive increase in MG loss percentage and staging from baseline (14.7 ± 6.2%; stage 0.8 ± 0.5) to 1 month (21.3 ± 6.5%; stage 1.3 ± 0.4) and 3 months (31.6 ± 11%; stage 1.9 ± 0.6) ( P < 0.001). Conclusions: Systemic EGFR-I therapy may contribute to progressive MG loss, which may be associated with ocular side effects commonly observed in patients receiving these agents, including dry eye disease, blepharitis, and meibomitis. Early recognition and management of these complications by ophthalmologists may improve patient comfort and support adherence to oncologic treatment.
- 14 January 2026
- Published by Wolters Kluwer Health in Cornea
Impact of Systemic EGFR Inhibitors on Meibomian Glands: A Meibographic Analysis With Clinical Correlations
Purpose: Epidermal growth factor receptor (EGFR) signaling promotes meibomian gland (MG) epithelial and mesenchymal cell proliferation and is involved in MG morphogenesis. This study aimed to evaluate the impact of systemic EGFR inhibitor (EGFR-I) therapy on MG status using meibography, and its association with ocular surface clinical parameters. Methods: In this prospective study, 39 patients with no prior history of ocular surface disease who were scheduled to receive systemic EGFR-I therapy for various malignancies were enrolled. All participants underwent Schirmer test, tear film break-up time, ocular surface disease index questionnaire, noninvasive tear break-up time, and noncontact meibography using Sirius topography at baseline, and at 1 and 3 months after treatment initiation. MG loss was quantified and staged based on meibographic analysis. Results: Of the 39 participants, 28 (72%) were female and 11 (28%) were male, with a mean age of 61.8 ± 11 years. Baseline Schirmer test and tear film break-up time values (15.6 ± 4.2 mm and 13.2 ± 3.5 seconds) showed a significant reduction at 1 month (13.8 ± 3.8 mm; 11.1 ± 3.0 seconds), with a further decline observed at 3 months (8.1 ± 3.1 mm; 7.4 ± 2.7 seconds) ( P < 0.001). The mean ocular surface disease index score increased from 7.7 ± 6.9 at baseline to 11.6 ± 7.3 at 1 month and 30.3 ± 14.6 at 3 months ( P < 0.001). Noninvasive tear break-up time values decreased significantly at 3 months (5.9 ± 2.6 seconds) relative to baseline (11.1 ± 4.5 seconds) ( P < 0.001). Meibographic assessments revealed a progressive increase in MG loss percentage and staging from baseline (14.7 ± 6.2%; stage 0.8 ± 0.5) to 1 month (21.3 ± 6.5%; stage 1.3 ± 0.4) and 3 months (31.6 ± 11%; stage 1.9 ± 0.6) ( P < 0.001). Conclusions: Systemic EGFR-I therapy may contribute to progressive MG loss, which may be associated with ocular side effects commonly observed in patients receiving these agents, including dry eye disease, blepharitis, and meibomitis. Early recognition and management of these complications by ophthalmologists may improve patient comfort and support adherence to oncologic treatment.
- 13 January 2026
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 36 (4) , 1042-1047
Long-term surgical outcomes of primary silicone orbital implant after orbital evisceration in infectious versus non-infectious cases
Introduction: Even with recent improvements, the optimal timing of orbital implant placement after evisceration surgery – particularly in infected cases – remains unclear. This study aimed to compare the long-term outcomes of primary silicone orbital implants after evisceration for infectious and non-infectious causes, focusing mainly on implant-related complications such as exposure or extrusion. Methods: A total of 32 eyes that underwent evisceration were analyzed. Patients were divided into two groups: infectious causes (Group A, n = 10) and non-infectious causes (Group B, n = 22). Postoperative follow-up duration, implant size, histopathological results, and complications – including implant exposure or extrusion – were evaluated. Results: Demographic characteristics were similar between the groups. The mean follow-up duration was 34.0 ± 17.7 months in group A and 28.18 ± 18.1 months in group B ( p = 0.403). The mean implant size was 17.8 ± 2.6 mm in group A and 18.3 ± 1.8 mm in group B ( p = 0.693). Mild symblepharon occurred in 2 patients (20%) in group A, while upper lid ptosis was noted in 2 patients (9%) in group B. No cases of implant exposure, extrusion, or sympathetic ophthalmia were observed in either group. Conclusion: Orbital evisceration results in comparable long-term outcomes for both infectious and non-infectious indications, with no observed cases of implant exposure or extrusion. These findings support the safe use of primary silicone implants in both scenarios when appropriate surgical technique is applied and adequate postoperative follow-up is provided.
- 13 January 2026
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 36 (4) , 1042-1047
Long-term surgical outcomes of primary silicone orbital implant after orbital evisceration in infectious versus non-infectious cases
Introduction: Even with recent improvements, the optimal timing of orbital implant placement after evisceration surgery – particularly in infected cases – remains unclear. This study aimed to compare the long-term outcomes of primary silicone orbital implants after evisceration for infectious and non-infectious causes, focusing mainly on implant-related complications such as exposure or extrusion. Methods: A total of 32 eyes that underwent evisceration were analyzed. Patients were divided into two groups: infectious causes (Group A, n = 10) and non-infectious causes (Group B, n = 22). Postoperative follow-up duration, implant size, histopathological results, and complications – including implant exposure or extrusion – were evaluated. Results: Demographic characteristics were similar between the groups. The mean follow-up duration was 34.0 ± 17.7 months in group A and 28.18 ± 18.1 months in group B ( p = 0.403). The mean implant size was 17.8 ± 2.6 mm in group A and 18.3 ± 1.8 mm in group B ( p = 0.693). Mild symblepharon occurred in 2 patients (20%) in group A, while upper lid ptosis was noted in 2 patients (9%) in group B. No cases of implant exposure, extrusion, or sympathetic ophthalmia were observed in either group. Conclusion: Orbital evisceration results in comparable long-term outcomes for both infectious and non-infectious indications, with no observed cases of implant exposure or extrusion. These findings support the safe use of primary silicone implants in both scenarios when appropriate surgical technique is applied and adequate postoperative follow-up is provided.
- 7 November 2025
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 242 (11) , 1112-1115
Severe Eyelid Coloboma and Related Ocular Surface Disorders in Amniotic Band Syndrome
Amniotic band syndrome (ABS) is an extremely rare fetal congenital malformation in which fibrous amniotic bands occur and strangulate fetusʼs organs, causing clefts and amputations of the affected organs [1]. Two main pathogenic mechanisms are proposed for its development. The first, the exogenous theory, suggests that early amniotic rupture leads to the formation of fibrous bands that encircle the fetal body. The second, the endogenous theory, attributes the condition to a vascular origin, rejecting the idea that mesoblastic strings are a causal factor. Amniotic band syndrome can cause a variety of orbital and eyelid malformations, including eyelid colobomas and facial clefts. These malformations can be severe, highly variable, and do not follow typical embryological development patterns [2], [3]. The most common ocular problems are congenital or acquired corneal leukomas, which occur secondary to ocular surface exposure caused by eyelid colobomas [4]. The goal of treatment is to restore eyelid anatomy while promoting the healing of the ocular surface. Although a definitive surgical method for treating these eyelid malformations has not been established, numerous reconstructive procedures are available, with the choice depending on the size of the defect [5], [6]. Here, we present a newborn diagnosed with ABS and severe eyelid coloboma, complicated by ocular surface problems, and discuss the management of this challenging case. Received: 04 October 2024 Accepted: 26 September 2025 Article published online: 07 November 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 7 November 2025
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 242 (11) , 1112-1115
Severe Eyelid Coloboma and Related Ocular Surface Disorders in Amniotic Band Syndrome
Amniotic band syndrome (ABS) is an extremely rare fetal congenital malformation in which fibrous amniotic bands occur and strangulate fetusʼs organs, causing clefts and amputations of the affected organs [1]. Two main pathogenic mechanisms are proposed for its development. The first, the exogenous theory, suggests that early amniotic rupture leads to the formation of fibrous bands that encircle the fetal body. The second, the endogenous theory, attributes the condition to a vascular origin, rejecting the idea that mesoblastic strings are a causal factor. Amniotic band syndrome can cause a variety of orbital and eyelid malformations, including eyelid colobomas and facial clefts. These malformations can be severe, highly variable, and do not follow typical embryological development patterns [2], [3]. The most common ocular problems are congenital or acquired corneal leukomas, which occur secondary to ocular surface exposure caused by eyelid colobomas [4]. The goal of treatment is to restore eyelid anatomy while promoting the healing of the ocular surface. Although a definitive surgical method for treating these eyelid malformations has not been established, numerous reconstructive procedures are available, with the choice depending on the size of the defect [5], [6]. Here, we present a newborn diagnosed with ABS and severe eyelid coloboma, complicated by ocular surface problems, and discuss the management of this challenging case. Received: 04 October 2024 Accepted: 26 September 2025 Article published online: 07 November 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 3 July 2025
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 42 (1) , 65-70
Lacrimal Gland Fibrosis in Patients With Moderate-to-Severe Thyroid Eye Disease
Purpose: To evaluate the elasticity and size of the lacrimal gland (LG) in patients with moderate-to-severe thyroid eye disease (TED) using strain ultrasound elastography and to compare these results with those of healthy subjects. Methods: This prospective, comparative case series included the right eyes of 26 patients with bilateral inactive moderate-to-severe TED and 49 healthy subjects, who served as the control group. Schirmer test, tear breakup time, ocular surface disease index, and corneal staining were assessed in both groups. The anteroposterior and transverse diameters of the LG were measured, and the strain index of the LG was calculated as the ratio of the LG to orbital fat tissue. Results: The anteroposterior diameter of the LG was 4.18 ± 1.02 mm in the TED group and 5.32 ± 1.54 mm in the control group ( p = 0.002). The transverse diameter of the LG was 7.48 ± 1.63 mm in the TED group and 9.46 ± 2.61 mm in the control group ( p = 0.001). The strain index of the LG was 3.91 ± 1.40 in the TED group and 1.03 ± 0.62 in the control group ( p < 0.001). Schirmer test and tear breakup time values were significantly lower, while ocular surface disease index scores and corneal staining scores were significantly higher in the TED group compared with the control group. Discussion: Strain ultrasound elastography revealed that the LGs of TED patients were stiffer than those of healthy subjects. Additionally, both the anteroposterior and transverse diameters of the LG were smaller in the TED group. These findings suggest that increased LG stiffness and reduced size may contribute to dry eye symptoms.
- 3 July 2025
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 42 (1) , 65-70
Lacrimal Gland Fibrosis in Patients With Moderate-to-Severe Thyroid Eye Disease
Purpose: To evaluate the elasticity and size of the lacrimal gland (LG) in patients with moderate-to-severe thyroid eye disease (TED) using strain ultrasound elastography and to compare these results with those of healthy subjects. Methods: This prospective, comparative case series included the right eyes of 26 patients with bilateral inactive moderate-to-severe TED and 49 healthy subjects, who served as the control group. Schirmer test, tear breakup time, ocular surface disease index, and corneal staining were assessed in both groups. The anteroposterior and transverse diameters of the LG were measured, and the strain index of the LG was calculated as the ratio of the LG to orbital fat tissue. Results: The anteroposterior diameter of the LG was 4.18 ± 1.02 mm in the TED group and 5.32 ± 1.54 mm in the control group ( p = 0.002). The transverse diameter of the LG was 7.48 ± 1.63 mm in the TED group and 9.46 ± 2.61 mm in the control group ( p = 0.001). The strain index of the LG was 3.91 ± 1.40 in the TED group and 1.03 ± 0.62 in the control group ( p < 0.001). Schirmer test and tear breakup time values were significantly lower, while ocular surface disease index scores and corneal staining scores were significantly higher in the TED group compared with the control group. Discussion: Strain ultrasound elastography revealed that the LGs of TED patients were stiffer than those of healthy subjects. Additionally, both the anteroposterior and transverse diameters of the LG were smaller in the TED group. These findings suggest that increased LG stiffness and reduced size may contribute to dry eye symptoms.
- Open Access
- 2 January 2025
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 54 (6) , 324-329
Publication Rates of Oculoplastic Surgery and Orbit Abstracts Presented at Turkish Ophthalmological Association National Congresses: 10-Year Analysis
Publication Rates of Oculoplastic Surgery and Orbit Abstracts Presented at Turkish Ophthalmological Association National Congresses: 10-Year Analysis - Turkish Journal of Ophthalmology
- 2 January 2025
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 54 (6) , 324-329
Open AccessPublication Rates of Oculoplastic Surgery and Orbit Abstracts Presented at Turkish Ophthalmological Association National Congresses: 10-Year Analysis
Publication Rates of Oculoplastic Surgery and Orbit Abstracts Presented at Turkish Ophthalmological Association National Congresses: 10-Year Analysis - Turkish Journal of Ophthalmology
- Open Access
- 1 January 2025
- Published by Kare Publishing in Beyoglu Eye Journal
- Vol. 10 (3) , 188-193
Primary Localized Conjunctival Amyloidosis Mimicking Lymphoma
A 27-year-old healthy male presented to our clinic with complaints of redness and burning in his left eye for the past 6 months. Biomicroscopic examination revealed a salmon-colored, elevated, painless mass lesion involving the entire lower fornix conjunctiva of the left eye. A conjunctival incisional biopsy was performed due to suspicion of lymphoproliferative disease. Histopathological examination confirmed amyloidosis. Further investigations did not reveal any evidence of systemic amyloidosis, lymphoma, or other lymphoproliferative diseases. During the 18-month follow-up after surgery, no recurrence or new findings were observed in the patient’s ophthalmologic or systemic evaluations. Amyloidosis in the periocular region can present with various clinical findings. Although a classic salmon-colored conjunctival mass initially may suggest lymphoproliferative diseases, conjunctival amyloidosis should be considered in the differential diagnosis.
- 1 January 2025
- Published by Kare Publishing in Beyoglu Eye Journal
- Vol. 10 (3) , 188-193
Open AccessPrimary Localized Conjunctival Amyloidosis Mimicking Lymphoma
A 27-year-old healthy male presented to our clinic with complaints of redness and burning in his left eye for the past 6 months. Biomicroscopic examination revealed a salmon-colored, elevated, painless mass lesion involving the entire lower fornix conjunctiva of the left eye. A conjunctival incisional biopsy was performed due to suspicion of lymphoproliferative disease. Histopathological examination confirmed amyloidosis. Further investigations did not reveal any evidence of systemic amyloidosis, lymphoma, or other lymphoproliferative diseases. During the 18-month follow-up after surgery, no recurrence or new findings were observed in the patient’s ophthalmologic or systemic evaluations. Amyloidosis in the periocular region can present with various clinical findings. Although a classic salmon-colored conjunctival mass initially may suggest lymphoproliferative diseases, conjunctival amyloidosis should be considered in the differential diagnosis.
- 20 December 2024
- Published by Springer Nature in International Ophthalmology
- Vol. 45 (1) , 1-8
PCR-based characterization of nasal and ocular surface flora and functional analysis of bacterial metabolic pathways in congenital nasolacrimal duct obstruction
Purpose To evaluate the role of Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Serratia marcescens, and Moraxella catarrhalis in the nasal and ocular surface flora, along with their metabolic activities in children with unilateral congenital nasolacrimal duct obstruction (CNLDO). Methods Swabs were taken from the bilateral inferior meatus and ocular surface of 26 children with unilateral CNLDO before probing. Nasal and ocular surface swabs from non-operated eyes of children who underwent unilateral blepharoptosis or strabismus surgery formed the control group. The quantitative polymerase chain reaction (qPCR) method was used to analyze the samples. Results The detection of Streptococcus pneumoniae in the nasal flora, Staphylococcus aureus in the ocular surface flora, and Haemophilus influenzae and Serratia marcescens in both the nasal and ocular surface flora was higher on the obstructed sides of children with CNLDO compared to the controls (p < 0.05). Obstructed sides in children with CNLDO showed a significant difference for Moraxella catarrhalis in the ocular surface and Streptococcus pneumoniae, Staphylococcus aureus, Serratia marcescens, and Moraxella catarrhalis in the nasal flora compared to the patent sides (p < 0.05). Metabolite analysis revealed that betaine, L-carnitine, L-leucine, and L-alanine were negatively regulated in the presence of these bacteria. Conclusions Significant changes in bacterial composition in the nasal and ocular surface flora may be a cause or a result of CNLDO. More comprehensive microbiological studies that evaluate the entire microbiome would be helpful in understanding CNLDO.
- 20 December 2024
- Published by Springer Nature in International Ophthalmology
- Vol. 45 (1) , 1-8
PCR-based characterization of nasal and ocular surface flora and functional analysis of bacterial metabolic pathways in congenital nasolacrimal duct obstruction
Purpose To evaluate the role of Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Serratia marcescens, and Moraxella catarrhalis in the nasal and ocular surface flora, along with their metabolic activities in children with unilateral congenital nasolacrimal duct obstruction (CNLDO). Methods Swabs were taken from the bilateral inferior meatus and ocular surface of 26 children with unilateral CNLDO before probing. Nasal and ocular surface swabs from non-operated eyes of children who underwent unilateral blepharoptosis or strabismus surgery formed the control group. The quantitative polymerase chain reaction (qPCR) method was used to analyze the samples. Results The detection of Streptococcus pneumoniae in the nasal flora, Staphylococcus aureus in the ocular surface flora, and Haemophilus influenzae and Serratia marcescens in both the nasal and ocular surface flora was higher on the obstructed sides of children with CNLDO compared to the controls (p < 0.05). Obstructed sides in children with CNLDO showed a significant difference for Moraxella catarrhalis in the ocular surface and Streptococcus pneumoniae, Staphylococcus aureus, Serratia marcescens, and Moraxella catarrhalis in the nasal flora compared to the patent sides (p < 0.05). Metabolite analysis revealed that betaine, L-carnitine, L-leucine, and L-alanine were negatively regulated in the presence of these bacteria. Conclusions Significant changes in bacterial composition in the nasal and ocular surface flora may be a cause or a result of CNLDO. More comprehensive microbiological studies that evaluate the entire microbiome would be helpful in understanding CNLDO.
- 13 December 2024
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- Vol. 44 (1) , 50-54
Effects of systemic fingolimod treatment on anterior segment parameters and tear film functions
To investigate the potential effects of systemic fingolimod treatment on parameters of the anterior segment of the eye and tear film function tests in patients with multiple sclerosis (MS). Forty-eight eyes of 24 individuals who were started on systemic fingolimod treatment for relapsing-remitting MS were prospectively enrolled in this study. Patients underwent examinations immediately before initiation of systemic fingolimod treatment, and at the first and sixth months of treatment. Anterior segment parameters were measured using Sirius Topography. The Schirmer-I test and tear break-up time (TBUT) were recorded during follow-up. Retinal thickness was also analyzed using spectral-domain optical coherence tomography (SD-OCT). There was no statistically significant difference in retinal thickness measurements between follow-up visits. The central corneal thickness, keratometric values, anterior chamber depth, aqueous humor depth, iridocorneal angle, horizontal anterior chamber tilt and anterior chamber volume values remained similar during follow-up. The Schirmer-I test value was 15.10 ± 2.65 mm at the zeroth month and 17.03 ± 3.61 mm at the sixth month (p = 0.044). The mean TBUT was significantly higher at the six-month visit compared to baseline and the one-month visit (p0-6 < 0.001, p1-6 < 0.001), but there was no statistically significant difference between baseline and month 1 (p0-1 = 0.419). Systemic use of fingolimod may increase Schirmer I test and TBUT values in MS patients without altering other anterior segment parameters within 6 months.
- 13 December 2024
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- Vol. 44 (1) , 50-54
Effects of systemic fingolimod treatment on anterior segment parameters and tear film functions
To investigate the potential effects of systemic fingolimod treatment on parameters of the anterior segment of the eye and tear film function tests in patients with multiple sclerosis (MS). Forty-eight eyes of 24 individuals who were started on systemic fingolimod treatment for relapsing-remitting MS were prospectively enrolled in this study. Patients underwent examinations immediately before initiation of systemic fingolimod treatment, and at the first and sixth months of treatment. Anterior segment parameters were measured using Sirius Topography. The Schirmer-I test and tear break-up time (TBUT) were recorded during follow-up. Retinal thickness was also analyzed using spectral-domain optical coherence tomography (SD-OCT). There was no statistically significant difference in retinal thickness measurements between follow-up visits. The central corneal thickness, keratometric values, anterior chamber depth, aqueous humor depth, iridocorneal angle, horizontal anterior chamber tilt and anterior chamber volume values remained similar during follow-up. The Schirmer-I test value was 15.10 ± 2.65 mm at the zeroth month and 17.03 ± 3.61 mm at the sixth month (p = 0.044). The mean TBUT was significantly higher at the six-month visit compared to baseline and the one-month visit (p0-6 < 0.001, p1-6 < 0.001), but there was no statistically significant difference between baseline and month 1 (p0-1 = 0.419). Systemic use of fingolimod may increase Schirmer I test and TBUT values in MS patients without altering other anterior segment parameters within 6 months.